The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

King Faisal Specialist Hospital & Research Center

Status: Unknown

Conditions: Advanced Breast Cancer

Treatments: Other: GnRh Analogue and Aromatase Inhibitor

Study type: Observational

Funder types: Other

Identifiers

NCT01311037

RAC# 2081-064

Details and patient eligibility

About

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Full description

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.

Enrollment: 2 estimated patients

Sex: Female

Ages: 45 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Receptor Positive Premenopausal Women with Advanced Breast Cancer.

Exclusion criteria

• Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.